Partner Content Partner Content PRISYM ID joins Siemens Digital Industries Software Solution PRISYM ID is partnering with Siemens
Views & Analysis Disrupting healthcare: 4 lessons from emerging markets Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
